Urist Marshall
Reporting owner on Forms 3, 4 and 5, CIK 1838139.
Urist Marshall reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-10-05.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| Royalty Pharma plc CIK 1802768 | officer (EVP, Research & Investments) | 2 | 2026-10-05 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| Royalty Pharma plc Class A Ordinary Shares | 2026-10-05 | S sold | -4,126 | $57.1 | 0 | Form 4 |
| Royalty Pharma plc Class A Ordinary Shares, holding | 19,020 | Form 4 | ||||
| Royalty Pharma plc Class A Ordinary Shares | 2026-09-28 | S sold | -4,126 | $57.88 | 4,126 | Form 4 |
| Royalty Pharma plc Class A Ordinary Shares, holding | 19,020 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001838139-26-000028 | Royalty Pharma plc | 2026-10-05 | ||
| Form 4 0001838139-26-000026 | Royalty Pharma plc | 2026-09-30 |